Pricing Log in Create free account
Saturday 17 October 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.48%, free cash flow grew 17.4% and total debt rose 37.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

79.20 0.78 +0.99%
Market cap
$32.4B
P/E
13.0×
Fwd P/E
12.3×
Dividend yield
2.64%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zoetis Inc. (ZTS) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Zoetis Inc. (ZTS) trades at a P/E ratio of 13.0×. Over the past ten years it has ranged from 11.4× (October 2026) to 70.6× (January 2016); the current reading is higher than 3% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 20.9× (29.82%)
FY2024 29.7× (23.31%)
FY2023 38.8× 19.07%
FY2022 32.6× (42.63%)
FY2021 56.8× 17.96%
FY2020 48.1× 14.14%
FY2019 42.1× 45.36%
FY2018 29.0× (28.89%)
FY2017 40.8× 25.55%
FY2016 32.5× (53.91%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 11.8× (39.61%)
Mar 2026 19.6× (6.20%)
Dec 2025 20.9× (15.29%)
Sep 2025 24.6× (8.07%)
42 more quarters

Against its own ten years

Low 11.4× High 70.6×
Ten-year median 38.1×
Current reading's percentile 4

P/E ratio against peers

Company P/E ratio
VTRS Viatris Inc. compare n/m
ELAN Elanco Animal Health Incorporated compare n/m
ZTS Zoetis Inc. 13.0×
UTHR United Therapeutics Corporation compare 17.6×
NBIX Neurocrine Biosciences, Inc. compare 19.2×
HLN Haleon PLC Sponsored ADR compare 22.6×
TAK Takeda Pharmaceutical Co. compare 29.6×
RDY Dr. Reddy's Laboratories Ltd compare 32.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 65.9×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ZTS